Form D · Other Health Care

FSD Pharma Inc.

Cobourg, A6 · CIK 0001771885

Offering snapshot reported Nov 20, 2019 · SEC filing

Reported sold
$10K
Offering amount: $10K
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Nov 4, 2019
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 20, 2019Initial$10,040No comparison1SEC filing
Oct 15, 2019Initial$2,625,000No comparison12SEC filing

Offering details

Securities
Equity, Other
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-353780
Class B Subordinate Voting Shares at CAD$20.10 per share.
Class B Subordinate Voting Shares at CAD$20.10 per share.

Source: Form D, filed Nov 20, 2019. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Dr. Raza Bohkari Director, Executive
Raza Bokhari Director, Executive
Edward Brennan Executive
Stephen Buyer Director
Donal Carroll Executive
Robert J Ciaruffoli Director
James A Datin Director
Anthony Durkacz Director
Thomas Fairfull Promoter
Gerald Goldberg Director
Sandy Huard Executive
Sara May Executive
Zeeshan Saeed Director, Executive
David Urban Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:
520 William Street
Cobourg, A6, K9A 3A5